Simplify Logo

Full-Time

Sr. Analyst

Quality Control Analytical

Confirmed live in the last 24 hours

Revance

Revance

501-1,000 employees

Biotechnology company for aesthetic solutions

Fintech
Biotechnology
Healthcare

Compensation Overview

$89k - $122.1kAnnually

Senior

Newark, CA, USA

100% onsite in Newark, CA.

Category
Lab & Research
Life Sciences
Requirements
  • Master’s degree & 2 years’ directly related experience
  • Bachelor’s degree & 5 years’ directly related experience
  • 5-7 years in a Quality Control laboratory environment (GMP environment) within a commercial setting.
  • Hands-on experience with a wide range of analytical techniques such as ELISA, SDS-PAGE, Western Blot, Karl Fisher and HPLC (SEC, IEX, HIC, RP, affinity).
  • Writing and or authoring deviations, lab investigations, protocols, SOPs, reports, and data trending.
  • Prior experience working in method validations, method transfers, raw material and stability testing is a plus.
  • Must be able to maintain data integrity, and understanding of US and international (e.g. EU, ICH, GXP) regulations.
  • Ability to manage multiple tasks and meet deadlines with a high tolerance for ambiguity, solutions oriented, and able to problem solve and identify root causes.
Responsibilities
  • Perform routine and non-routine release, in-process and stability testing for drug substance, drug product, and other critical reagents and documentation under cGMP.
  • Perform Analytical assays such as HPLC (SEC, IEX, HIC, RP, affinity), ELISA, SDS-PAGE, Western Blot, Water Content, UV, Appearance and pH.
  • Independently author and lead quality records such as Deviations, Lab Investigations, CAPA, Change Control including leading thorough and timely investigation and/or implementation activities.
  • Author and revise SOPs as needed.
  • Lead and/or support method development, optimization, transfer, qualification, and validation activities of analytical methods.
  • Support equipment and software qualification and maintenance activities.
  • Review of laboratory records generated in support of QC testing including procedures, methods, audit trails and other controlled documents.
  • Provide training to laboratory analysts as needed, and guide junior analysts in the lab environment, including troubleshooting.
  • Work on multiple projects to meet departmental and organization goals.
  • Work collaboratively with Manufacturing, QA and Regulatory to support CMC analytical deliverables.

Revance Therapeutics, Inc. specializes in aesthetic and therapeutic solutions, primarily focusing on products that enhance physical appearance and improve patient outcomes. The company offers neuromodulators, like botulinum toxin type A, which reduce wrinkles and treat muscle movement disorders, and dermal fillers that restore volume and smooth facial lines. Revance is also exploring therapeutic uses for its products in muscle movement and pain disorders. Additionally, the company has expanded into the fintech sector with the acquisition of HintMD, a platform that streamlines payment processes for aesthetic practices. This integration allows Revance to provide a comprehensive suite of services to support aesthetic practitioners. Unlike its competitors, Revance emphasizes differentiated products and improved patient experiences, aiming to establish itself as a leader in the premium aesthetics market.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Nashville, Tennessee

Founded

1999

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-12%

2 year growth

11%
Simplify Jobs

Simplify's Take

What believers are saying

  • Revance's partnership with Viatris to commercialize DAXXIFY in China opens up significant international market opportunities.
  • The launch of DAXXIFY for cervical dystonia treatment positions Revance as a key player in the U.S. therapeutics neurotoxin market.
  • The company's $100 million public offering indicates strong investor confidence and provides capital for further expansion and innovation.

What critics are saying

  • The biotech and aesthetics markets are highly competitive, requiring continuous innovation to maintain market share.
  • Regulatory hurdles and FDA approvals can delay product launches and impact revenue streams.

What makes Revance unique

  • Revance's integration of fintech solutions like HintMD into its aesthetic offerings provides a unique value proposition that competitors in the biotech space lack.
  • The company's focus on both aesthetic and therapeutic applications for neuromodulators and dermal fillers sets it apart from competitors who may focus solely on one area.
  • Revance's recent launch of DAXXIFY for cervical dystonia treatment highlights its commitment to expanding into therapeutic markets, differentiating it from purely aesthetic-focused companies.

Help us improve and share your feedback! Did you find this helpful?